Member Info for Servalan

More great news, more idiots selling it. Take your beer money and eff off, I want the brewery.

What can be done to stop UBS' ability to control this share seemingly at will? Extremely frustrating to see them stoke then kill any meaningful and lasting rise here.

Absolute dodo brains selling at this price.

The smooth brains selling this now for beer money deserve everything they get - crumbs instead of waiting for the cake

Openprescribing.net/chemical/0901011Y0/#

If it doesn't work got to open prescribing and search for ferric maltol

£149,691 (June 2025: £132,987 - July 2024: £107,958). 38%+ increase yoy !

Totally agree, Tired. UK biotech is littered with corpses of decent companies badly run and/or run out of cash. Angle seems to be next to go so i need to bank here to make up for it.

Hopefully the start of the next leg up to 10p and far beyond. I'm fine with a buyout at a sensible price. UK biotechs face such an uphill struggle in a way that their US equivalents never do. They deserve success and if the UK can't understand or appreciate it then some other company elsewhere can.

Bots - you don't get to post your views and then police a board telling everyone to "move on"

"extreme lefties" - he was an extreme right-wing rage baiter. A typical US fake Christian who was anything but in his views. You encourage rage, you can expect it back at you.

Can't anyone hold for more than 30 seconds any more?!

We should be way north of 10p on that news alone.

Great news today, continues to show how ridiculously undervalued this company is. Just no more silly mistakes please!

Oh no! i tiny minor accounting error of no significance, quick everyone sell! panic, sell, sell sell, flee, sell, it's all over. We're all doomed!

Just look at the Rx graph for NHS England. Bizarre why anyone would sell now. Each to their own of course but this is so undervalued in my opinion. I'll happily take your shares from you. If this was a US biotech, it would not be at 8c.

Thank you for that. Yes, it is strangely quiet even with the wider biotech/med tech space having a bit of moment. I wonder how much effect the GLP market is having on all things diabetes with more indications coming out for them. Take a pill and all will be fine, apparently. Still confident this will have its day in the sun.

What a disappointing way to end a great run this month. There is so much more to come here if performance stays on track.

Can someone explain the constant in/out of UBS? is it that they are just over and then under the reporting threshold? Thanks.

You can't have a buy without a sell ...

It's about time it was re-rated to somewhere more sensible. I just...hope...they aren't running it up for another reason. We all know what they are like.